Formation Bio, which uses AI to co-develop drugs with biotech and pharma companies, raised a $372M Series D led by a16z, bringing its total funding to $600M+ (Kyle Wiggers/TechCrunch)

Kyle Wiggers / TechCrunch:
Formation Bio, which uses AI to co-develop drugs with biotech and pharma companies, raised a $372M Series D led by a16z, bringing its total funding to $600M+  —  Formation Bio, a startup focused on applying AI to drug discovery with backing from OpenAI CEO Sam Altman, has raised …